Volume 66, Issue 2, Pages (August 2004)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Volume 63, Issue 2, Pages (February 2003)
Volume 65, Issue 6, Pages (June 2004)
Volume 54, Issue 2, Pages (August 1998)
Volume 59, Issue 3, Pages (March 2001)
E. Cavalier, P. Delanaye, A. Carlisi, J. -M. Krzesinski, J. -P
Nutrition and chronic kidney disease
Volume 70, Issue 8, Pages (October 2006)
Volume 88, Issue 5, Pages (November 2015)
Linear and logistic regression analysis
Volume 83, Issue 4, Pages (April 2013)
Iron status and iron supplementation in peritoneal dialysis patients
Volume 60, Issue 2, Pages (August 2001)
Volume 58, Issue 4, Pages (October 2000)
Volume 60, Issue 5, Pages (November 2001)
Volume 62, Issue 2, Pages (August 2002)
Volume 63, Issue 6, Pages (June 2003)
Hua Liu, Steven A. Bigler, Jeffrey R. Henegar, Radhakrishna Baliga 
Volume 54, Issue 2, Pages (August 1998)
Neal X. Chen, Kalisha D. O'Neill, Danxia Duan, Sharon M. Moe 
Volume 59, Issue 6, Pages (June 2001)
Kamyar Kalantar-Zadeh  Kidney International 
Volume 58, Issue 1, Pages (July 2000)
George A. Kaysen, Burl R. Don
C.-C. Yang, S.-P. Hsu, M.-S. Wu, S.-M. Hsu, C.-T. Chien 
Nutrition and chronic kidney disease
Volume 54, Issue 2, Pages (August 1998)
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
Joseph W. Eschbach, John W. Adamson  Kidney International 
Body weight is a fluctuating parameter in hemodialysis patients
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells  Ingeborg A. Hauser,
Volume 60, Issue 3, Pages (September 2001)
Volume 68, Issue 2, Pages (August 2005)
Blood pressure targets in hemodialysis patients
Volume 67, Issue 1, Pages (January 2005)
Volume 65, Issue 6, Pages (June 2004)
Albumin-like material in urine
Volume 73, Issue 9, Pages (May 2008)
Fractional clearance of high molecular weight proteins in conscious rats using a continuous infusion method  Melissa J. Burne, Tanya M. Osicka, Wayne.
Volume 56, Pages S31-S37 (December 1999)
Volume 61, Issue 6, Pages (June 2002)
Volume 69, Issue 1, Pages (January 2006)
Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering  Bettina Haslinger, Martin F. Goedde,
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
The value of ferric citrate, an iron-containing phosphate binder, might be different between Japan and the United States  Keitaro Yokoyama, Yukio Maruyama,
Increased endothelin-1 expression in the kidney in hypercalcemic rats
Volume 54, Issue 2, Pages (August 1998)
Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress  Marjorie E. Dunlop,
Volume 58, Issue 2, Pages (August 2000)
Volume 56, Issue 5, Pages (November 1999)
Volume 65, Issue 3, Pages (March 2004)
Volume 58, Issue 5, Pages (November 2000)
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Steven J. Harper, Charles R.V. Tomson, David O. Bates 
Volume 63, Issue 3, Pages (March 2003)
Volume 80, Issue 10, Pages (November 2011)
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 80, Issue 10, Pages (November 2011)
Reduced content of α subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: Relationship with vascular hyporeactivity  Lorenzo.
Volume 70, Issue 8, Pages (October 2006)
Volume 71, Issue 9, Pages (May 2007)
Successful Treatment of a Patient With Severe Calcific Uremic Arteriolopathy (Calciphylaxis) by Etidronate Disodium  Naoki Shiraishi, MD, PhD, Kenichiro.
Increased plasma protein homocysteinylation in hemodialysis patients
Volume 75, Issue 9, Pages (May 2009)
Volume 59, Issue 3, Pages (March 2001)
Volume 62, Issue 5, Pages (November 2002)
Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies  Michael Eikmans, Hans J. Baelde, Emile De Heer,
Presentation transcript:

Volume 66, Issue 2, Pages 841-848 (August 2004) Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients  Makoto Anraku, Kenichiro Kitamura, Ayumi Shinohara, Masataka Adachi, Ayaka Suenaga, Toru Maruyama, Kei Miyanaka, Taku Miyoshi, Naoki Shiraishi, Hiroshi Nonoguchi, Masaki Otagiri, Kimio Tomita  Kidney International  Volume 66, Issue 2, Pages 841-848 (August 2004) DOI: 10.1111/j.1523-1755.2004.00813.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 High-performance liquid chromatography (HPLC) profile of in vitro–oxidized serum albumin. HPLC profile of albumin from a normal subject under basal condition (A). Serum was incubated with 200 μmol/L of H2O2 in the presence or absence of 180 μmol/L of saccharated ferric oxide for 1 hour (B and D) or 24 hours (C and E). Five-μL aliquots of each serum were analyzed by HPLC using a Shodex Asahipak ES-502N column. HMA; mercaptalbumin (reduced form), HNA-1; nonmercaptalbumin (disulfide form), HNA-2; nonmercaptalbumin (oxidized form). Kidney International 2004 66, 841-848DOI: (10.1111/j.1523-1755.2004.00813.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 High-performance liquid chromatography (HPLC) profile of serum albumin from HD patients with or without intravenous iron administration (IVIR). Five-μL aliquots of serum from HD patients with or without IVIR, and healthy subjects were subjected to HPLC analysis using a Shodex Asahipak ES-502N column. A representative tracing of HPLC profiles of serum albumin from normal subjects (A). A representative tracing of HPLC profiles of serum albumin from HD patients without IVIR (B). A representative tracing of HPLC profile of serum albumin from patients treated with IVIR (C). Kidney International 2004 66, 841-848DOI: (10.1111/j.1523-1755.2004.00813.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Carbonyl content of major plasma proteins from normal subjects and HD patients with or without intravenous iron administration (IVIR). Plasma samples from HD patients with or without IVIR were derivatized with DNP and subjected to duplicate SDS-PAGE gels (A). Following electrotransfer, one blot was stained with Coomassie brilliant blue G for protein (upper blot) and the second blot was stained for DNP using OxiBlot kit reagents (lower blot). Carbonyl formation of major plasma proteins (albumin, transferrin, immunoglobulin, and fibrinogen) were determined as densitometry ratio of DNP area and protein area, and are reported in densitometry units (B). Values are expressed as mean ± SE; N = 11 patients per group. *P < 0.05 as compared with plasma from patients without IVIR. Kidney International 2004 66, 841-848DOI: (10.1111/j.1523-1755.2004.00813.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Relationship between plasma protein carbonyl content and f(HNA-1) (A) or f(HNA-2) (B). Plasma protein carbonyl contents and f(HNA-1) or f(HNA-2) values from normal subjects and HD patients with or without intravenous iron administration (IVIR) are plotted, and the line shows linear regression of plasma protein carbonyl content and f(HNA-1) or f(HNA-2) values (N = 33, R = 0.674 and R = 0.724, respectively, P < 0.01). Kidney International 2004 66, 841-848DOI: (10.1111/j.1523-1755.2004.00813.x) Copyright © 2004 International Society of Nephrology Terms and Conditions